EUROSEAS LTD. (ESEA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 0.86%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value 10.30×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.86% | Share-based compensation / revenue. Period ending 2025-12-31. $1.96M ÷ $227.87M × 100 ≈ 0.86% |
| Interest coverage · 12 months | 10.30× | Operating income ÷ reported interest expense. $149.50M ÷ $14.52M ≈ 10.30× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 227.87M USD | |
| Stock-based compensation | 1.96M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 149.50M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 14.52M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | $227.87M | $1.96M | $149.50M | $14.52M | (m) | 0.86% | 10.30× | Reported |
| 2025-06-30 | (m) | $221.03M | $1.83M | $131.15M | $14.10M | (m) | 0.83% | 9.30× | Reported |
| 2024-12-31 | (m) | $212.90M | $1.52M | $120.02M | $10.08M | (m) | 0.71% | 11.90× | Reported |
| 2024-06-30 | (m) | $205.17M | $1.11M | $123.65M | $7.72M | (m) | 0.54% | 16.01× | Reported |
| 2023-12-31 | (m) | $189.36M | $1.08M | $119.43M | $5.96M | (m) | 0.57% | 20.05× | Reported |
| 2023-06-30 | (m) | $178.47M | $1.20M | $104.66M | $4.67M | (m) | 0.67% | 22.41× | Reported |
| 2022-12-31 | (m) | $182.69M | $951.38K | $106.64M | $4.73M | (m) | 0.52% | 22.55× | Reported |
| 2022-06-30 | (m) | $155.15M | $555.98K | $93.48M | $3.32M | (m) | 0.36% | 28.15× | Reported |
| 2021-12-31 | (m) | $93.89M | $182.32K | $45.73M | $2.56M | (m) | 0.19% | 17.89× | Reported |
| 2021-09-30 | (m) | $67.67M | $103.76K | $23.69M | $2.52M | (m) | 0.15% | 9.40× | Reported |
| 2021-06-30 | (m) | $56.96M | $118.67K | $15.94M | $2.83M | (m) | 0.21% | 5.63× | Reported |
| 2021-03-31 | (m) | $52.18M | $119.99K | $10.09M | $3.28M | (m) | 0.23% | 3.08× | Reported |
| 2020-12-31 | (m) | $53.30M | $121.63K | $9.29M | $3.84M | (m) | 0.23% | 2.42× | Reported |
| 2020-09-30 | (m) | $54.58M | $117.06K | $7.77M | $4.27M | (m) | 0.21% | 1.82× | Reported |
| 2020-06-30 | (m) | $52.55M | $109.16K | $7.12M | $4.15M | (m) | 0.21% | 1.72× | Reported |
| 2020-03-31 | (m) | $47.12M | $103.46K | $4.50M | $3.76M | (m) | 0.22% | 1.20× | Reported |
| 2019-12-31 | (m) | $40.02M | $97.92K | $1.98M | $3.22M | (m) | 0.24% | 0.61× | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $32.79M | $77.88K | $1.20M | $2.93M | (m) | 0.24% | 0.41× | Reported |
| 2019-03-31 | (m) | $34.46M | $90.48K | $3.78M | $2.77M | (m) | 0.26% | 1.36× | Reported |
| 2018-12-31 | (m) | $34.42M | $124.49K | $2.34M | $2.70M | (m) | 0.36% | 0.86× | Reported |
| 2018-06-30 | (m) | (m) | $138.03K | $726.06K | $3.47M | (m) | (m) | 0.21× | Reported |
| 2018-03-31 | (m) | $23.77M | $134.97K | $-4.75M | $1.33M | (m) | 0.57% | -3.57× | Reported |
| 2017-12-31 | (m) | $42.92M | $116.56K | $-2.78M | $2.99M | (m) | 0.27% | -0.93× | Reported |
| 2017-06-30 | (m) | $32.84M | $228.92K | $-16.44M | $2.63M | (m) | 0.70% | -6.25× | Reported |
| 2017-03-31 | (m) | $30.17M | $266.38K | $-20.65M | $2.33M | (m) | 0.88% | -8.87× | Reported |
| 2016-12-31 | (m) | $28.42M | $294.34K | $-21.64M | $1.92M | (m) | 1.04% | -11.28× | Reported |
| 2016-09-30 | (m) | $29.93M | $272.09K | $-13.42M | (m) | (m) | 0.91% | (m) | (m) |
| 2016-06-30 | (m) | $34.02M | $224.17K | $-10.81M | (m) | (m) | 0.66% | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $37.68M | $306.11K | $-11.40M | $1.35M | (m) | 0.81% | -8.43× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $39.05M | $445.71K | $-16.34M | (m) | (m) | 1.14% | (m) | (m) |
| 2014-12-31 | (m) | $40.63M | $510.11K | $-14.63M | (m) | (m) | 1.26% | (m) | (m) |
| 2014-06-30 | (m) | (m) | $487.37K | $-93.72M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $568.33K | $-99.95M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $46.26M | $712.31K | $-12.93M | (m) | (m) | 1.54% | (m) | (m) |
| 2012-12-31 | (m) | $52.49M | $671.38K | $-9.88M | (m) | (m) | 1.28% | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $61.40M | $568.49K | $4.81M | (m) | (m) | 0.93% | (m) | (m) |
| 2010-12-31 | (m) | $52.48M | $696.12K | $-709.23K | (m) | (m) | 1.33% | (m) | (m) |
| 2009-12-31 | (m) | $63.78M | $820.19K | $22.43K | (m) | (m) | 1.29% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.